These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36145629)

  • 21. Cocrystal formulations: A case study of topical formulations consisting of ferulic acid cocrystals.
    Aitipamula S; Das S
    Eur J Pharm Biopharm; 2020 Apr; 149():95-104. PubMed ID: 32035236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
    Li Z; Matzger AJ
    Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
    Rahman Z; Samy R; Sayeed VA; Khan MA
    Pharm Dev Technol; 2012; 17(4):457-65. PubMed ID: 21265708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combined experimental and theoretical study of miconazole salts and cocrystals: crystal structures, DFT computations, formation thermodynamics and solubility improvement.
    Drozd KV; Manin AN; Voronin AP; Boycov DE; Churakov AV; Perlovich GL
    Phys Chem Chem Phys; 2021 Jun; 23(21):12456-12470. PubMed ID: 34037030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physico-mechanical and stability evaluation of carbamazepine cocrystal with nicotinamide.
    Rahman Z; Agarabi C; Zidan AS; Khan SR; Khan MA
    AAPS PharmSciTech; 2011 Jun; 12(2):693-704. PubMed ID: 21598082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the formation of apremilast cocrystals.
    Dudek MK; Wielgus E; Paluch P; Śniechowska J; Kostrzewa M; Day GM; Bujacz GD; Potrzebowski MJ
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2019 Oct; 75(Pt 5):803-814. PubMed ID: 32830759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the Effects of a Polymer on the Surface Dissolution of Pharmaceutical Cocrystals Using Combined Experimental and Molecular Dynamics Simulation Approaches.
    Kirubakaran P; Wang K; Rosbottom I; Cross RBM; Li M
    Mol Pharm; 2020 Feb; 17(2):517-529. PubMed ID: 31887053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cocrystal formation, crystal structure, solubility and permeability studies for novel 1,2,4-thiadiazole derivative as a potent neuroprotector.
    Surov AO; Volkova TV; Churakov AV; Proshin AN; Terekhova IV; Perlovich GL
    Eur J Pharm Sci; 2017 Nov; 109():31-39. PubMed ID: 28756204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
    Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
    Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
    Qiao N; Wang K; Schlindwein W; Davies A; Li M
    Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Four Novel Pharmaceutical Cocrystals of Oxyresveratrol, Including a 2 : 3 Cocrystal with Betaine.
    Sakamoto N; Tsuno N; Koyama R; Gato K; Titapiwatanakun V; Takatori K; Fukami T
    Chem Pharm Bull (Tokyo); 2021; 69(10):995-1004. PubMed ID: 34602581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
    Boksa K; Otte A; Pinal R
    J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.
    Panzade P; Shendarkar G; Shaikh S; Balmukund Rathi P
    Adv Pharm Bull; 2017 Sep; 7(3):399-408. PubMed ID: 29071222
    [No Abstract]   [Full Text] [Related]  

  • 34. Preparation of pharmaceutical cocrystal formulations via melt mixing technique: A thermodynamic perspective.
    Barmpalexis P; Karagianni A; Nikolakakis I; Kachrimanis K
    Eur J Pharm Biopharm; 2018 Oct; 131():130-140. PubMed ID: 30092346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic Analysis of Cocrystal Dissolution as a Function of pH and Micellar Solubilization.
    Cao F; Amidon GL; Rodriguez-Hornedo N; Amidon GE
    Mol Pharm; 2016 Mar; 13(3):1030-46. PubMed ID: 26877267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering cocrystal solubility, stability, and pH(max) by micellar solubilization.
    Huang N; Rodríguez-Hornedo N
    J Pharm Sci; 2011 Dec; 100(12):5219-34. PubMed ID: 21910122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the Supramolecular Interactions and Thermal Stability of Dapsone:Bipyridine Cocrystals by Combining Computational Chemistry with Experimentation.
    Racher F; Petrick TL; Braun DE
    Cryst Growth Des; 2023 Jun; 23(6):4638-4654. PubMed ID: 37304396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hansen solubility parameter as a tool to predict cocrystal formation.
    Mohammad MA; Alhalaweh A; Velaga SP
    Int J Pharm; 2011 Apr; 407(1-2):63-71. PubMed ID: 21256944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daidzein cocrystals: An opportunity to improve its biopharmaceutical parameters.
    Bhalla Y; Chadha K; Chadha R; Karan M
    Heliyon; 2019 Nov; 5(11):e02669. PubMed ID: 31763466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting the Solubility of Pharmaceutical Cocrystals in Solvent/Anti-Solvent Mixtures.
    Lange L; Heisel S; Sadowski G
    Molecules; 2016 May; 21(5):. PubMed ID: 27164075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.